Kolexia
Alexandru Cristina Ramona
Oncologie médicale
Centre Henri-Becquerel
Rouen, France
49 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Glioblastome Tumeurs du sein Tumeurs du cerveau Métastase tumorale Thrombopénie Gliome Gliosarcome Méningite cryptococcique Méningite

Industries

Janssen
3 collaboration(s)
Dernière en 2023
Bayer
2 collaboration(s)
Dernière en 2021
AstraZeneca
2 collaboration(s)
Dernière en 2023
Lilly
1 collaboration(s)
Dernière en 2023

Dernières activités

Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients.
Translational oncology   09 février 2024
OLA-TMZ-RTE-01: Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients
Essai Clinique (Centre François-Baclesse)   02 janvier 2024
GLIOPLAK: Impact of the Platelet Level During Radiotherapy Associated With Temozolomide in Patients Treated for Glioblastoma
Essai Clinique (Centre Henri-Becquerel)   02 mai 2023
Impact of EGFR mutation on relapse pattern in glioblastoma.
ESMO open   23 décembre 2022
Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma.
Revue neurologique   21 juillet 2022
Impact of EGFRA289T/V mutation on relapse pattern in glioblastoma.
2022 ASCO Annual Meeting I   02 juin 2022
Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma.
Acta neuropathologica communications   04 novembre 2020
371MO Usefulness of circulating tumour DNA detection from cerebrospinal fluid in recurrent high-grade glioma
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
379P Impact of MGMT and ABCB1 single nucleotide polymorphisms on temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
FMER: Determination of ESR1 Mutations by Digital PCR During Aromatase Inhibitor Treatment in Metastatic Breast Cancer
Essai Clinique (Centre Henri-Becquerel)   29 juillet 2020